Ketorolac, classified under HS code 30049067, is subject to varying tariff treatments across key importing countries.
United States: The Most Favored Nation (MFN) tariff rate for HS code 30049067 is 0%, indicating duty-free entry for pharmaceuticals. Under the Generalized System of Preferences (GSP), India benefits from preferential treatment, further supporting duty-free access for eligible products. Essential medicines, including Ketorolac, are typically exempt from additional tariffs, aligning with U.S. policies to facilitate the importation of critical healthcare products.
Canada: According to the Canada Border Services Agency (CBSA), the MFN tariff rate for HS code 30049067 is 0%, allowing duty-free importation of pharmaceuticals. India is a beneficiary under Canada's General Preferential Tariff (GPT), which also offers a 0% rate for eligible products. Essential medicines are generally exempt from additional duties, ensuring accessible healthcare imports. (cbsa-asfc.gc.ca)
Russia: Russia's MFN tariff rate for HS code 30049067 is 0%, facilitating duty-free entry of pharmaceuticals. While there is no specific Free Trade Agreement (FTA) between Russia and India affecting this product, essential medicines like Ketorolac are often exempt from additional tariffs, reflecting Russia's commitment to healthcare accessibility.
Ecuador: Ecuador applies an MFN tariff rate of 0% to HS code 30049067, allowing duty-free importation of pharmaceuticals. Although there is no specific FTA between Ecuador and India for this product, essential medicines are typically exempt from additional duties, supporting public health initiatives.
United Arab Emirates (UAE): The UAE imposes an MFN tariff rate of 0% on HS code 30049067, ensuring duty-free entry of pharmaceuticals. While there is no specific FTA between the UAE and India for this product, essential medicines like Ketorolac are generally exempt from additional tariffs, aligning with the UAE's healthcare policies.
